Skip to main content
OpenTrials
Completed

NCT Number: NCT01331070

Identification and Dynamics With Cerebral Functional Magnetic Resonance Imaging

Chronic obstructive pulmonary disease (COPD) is a chronicle inflammatory disease with a non reversible diminution of the airway flow. COPD is caused most commonly from tobacco smoking, which triggers an abnormal inflammatory response in the lung. Worldwide, COPD ranked as the sixth leading cause of death in 1990. It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries. COPD is responsible for 16000 deaths per year in France, 100 000 hospitalizations per year and the health care expenditure of COPD in France is 3.5 billion of Euros. Classical markers of the disease severity, the forced expiratory volume in one second, poorly correlates with dyspnea and prognosis. Therefore, many studies focused on the control of breathing in an attempt to understand the pathophysiological mechanisms involved in the progression of the disease. Breathing control is enhanced in patients with COPD due to the progressive failure of respiratory muscles (airflow obstruction, static and dynamic hyperinflation, positive intrinsic end expiratory pressure), the ventilation/ perfusion ratio abnormalities leading to the loss of the gaz exchange efficiency. Inspiratory command depends on the medulla automatic pathway and the voluntary corticospinal command. Indirect method of breathing control estimation suggested in COPD patients an increased excitability of neurons involved in the voluntary diaphragm activation and a reduced cortical reserve. This may represent an increase risk factor for acute respiratory failure. Until now, no study reported the central breathing control with cerebral fMRI in COPD patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Bichat

Paris, 75018, France

About this study

Chronic obstructive pulmonary disease (COPD) is a chronicle inflammatory disease with a non reversible diminution of the airway flow. COPD is caused most commonly from tobacco smoking, which triggers an abnormal inflammatory response in the lung. Worldwide, COPD ranked as the sixth leading cause of death in 1990. It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries. COPD is responsible for 16000 deaths per year in France, 100 000 hospitalizations per year and the health care expenditure of COPD in France is 3.5 billion of Euros. Classical markers of the disease severity, the forced expiratory volume in one second, poorly correlates with dyspnea and prognosis. Therefore, many studies focused on the control of breathing in an attempt to understand the pathophysiological mechanisms involved in the progression of the disease. Breathing control is enhanced in patients with COPD due to the progressive failure of respiratory muscles (airflow obstruction, static and dynamic hyperinflation, positive intrinsic end expiratory pressure), the ventilation/ perfusion ratio abnormalities leading to the loss of the gaz exchange efficiency. Inspiratory command depends on the medulla automatic pathway and the voluntary corticospinal command. Indirect method of breathing control estimation suggested in COPD patients an increased excitability of neurons involved in the voluntary diaphragm activation and a reduced cortical reserve. This may represent an increase risk factor for acute respiratory failure. Until now, no study reported the central breathing control with cerebral fMRI in COPD patients. This pilot study also aims in estimating if the absence or diminution of the cortical reserve is a marker of disease severity. In addition correlations will be performed between activated neuronal signals with fMRI and ventilatory flow output recordings (chaotic analysis).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for Patient:

  • Informed patients with written consent,
  • More than eighteen years old,
  • Patients having a social insurance
  • A previous medical examination
  • Patients, half with moderate (GOLD II) and half with severe (GOLD III) COPD will be included. These patients will be clinically in a steady state situation for at least one month (no acute exacerbation). GOLD grading of COPD patients will be performed according to the American Thoracic Society.

Exclusion criteria

for patient:

  • Long-term oxygen therapy
  • Previous cerebral vascular accident
  • Central neurological disease (tumor, Parkinson, etc.)
  • Nobody benefiting from a particular protection: pregnant woman, minor person, major person under guardianship and under guardianship, the persons hospitalized without their consent and protected by the law, or the private persons of freedom.
  • Contraindication in the functional intellectual MRI:
  • Port of a biomedical device like cardiac simulator
  • Cardiac defibrillator
  • Insulin pump or neurostimulating,
  • Claustrophobia,
  • Impossibility to remain lengthened
  • Presence of cerebral vascular clips, metallic foreign body intra-ocular, not compatible cardiac valve
  • Pregnancy

Inclusion criteria

for Healthy Volunteers:

  • Informed healthy volunteer with written consent,
  • More than eighteen years old,
  • Healthy volunteer having a social insurance
  • A previous medical examination
  • Non-smoker
  • Non pathology and medicinal treatment

Exclusion criteria

for healthy volunteers:

  • Nobody benefiting from a particular protection: pregnant woman, minor person, major person under guardianship and under guardianship, the persons hospitalized without their consent and protected by the law, or the private persons of freedom.
  • Contraindication in the functional intellectual MRI:
  • Port of a biomedical device like cardiac simulator
  • Cardiac defibrillator
  • Insulin pump or neurostimulating,
  • Claustrophobia,
  • Impossibility to remain lengthened
  • Presence of cerebral vascular clips, metallic foreign body intra-ocular, not compatible cardiac valve
  • Pregnancy

Treatment and study plan

Cerebral fMRI

Other

the central breathing control with cerebral fMRI in COPD patients

Other names: the central breathing control with cerebral fMRI

Primary outcomes

  1. Central ventilatory control

    Time frame: 1 month

    Evaluation of the central ventilatory control at the patients COPD during the application of an inspiratory resistance.

Secondary outcomes

  1. Evaluation of the neuronal activation

    Time frame: 1 month

    Evaluation of the neuronal activation bulbo-pontique and corticospinal during the application of an inspiratory resistance.

  2. Chaotic analysis

    Time frame: 1 month

    The correlations will be performed between activated neuronal signals with fMRI and ventilatory flow output recordings (chaotic analysis).

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Central Control of Breathing in Patients With Chronic Obstructive Pulmonary Disease: Identification and Dynamics With Cerebral Functional Magnetic Resonance Imaging

Acronym: CHAOSBOLD

Important dates

Study start
2011
Primary completion
2012
Study completion
2013
First posted
Apr 7, 2011
Registry last updated
Aug 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.